Medical Properties Trust authorizes $150M buyback; Q3 results furnished

Medical Properties Trust (MPW) furnished third‑quarter 2025 results and announced a new stock repurchase program.

Rhea-AI Filing Summary

Medical Properties Trust (MPW) furnished third‑quarter 2025 results and announced a new stock repurchase program. The board approved the repurchase of up to $150 million of common stock.

Repurchases may occur through open market purchases, Rule 10b5‑1 trading plans, privately negotiated transactions, structured or derivative transactions, other equity contracts, or other permitted methods. The company is under no obligation to repurchase any shares and may begin, suspend, or terminate activity at any time at its discretion, considering liquidity, market conditions, regulatory factors, and the marginal benefit of new investments or debt reduction.

The press release covering financial results for the three and nine months ended September 30, 2025, and supplemental information were furnished as exhibits.

Insights

REIT capital markets analyst

$150M buyback adds optionality; execution discretionary.

Medical Properties Trust authorized up to $150,000,000 in common stock repurchases. The plan lists multiple pathways—open market purchases, Rule 10b5‑1 plans, privately negotiated and structured/derivative transactions—providing flexibility across trading conditions.

The authorization imposes no purchase obligation and can be started, paused, or terminated at the company’s discretion. Actual activity will depend on liquidity, market conditions, regulatory considerations, and relative benefits versus new investments or debt reduction, as stated.

The company also furnished Q3 2025 results and a supplemental package as exhibits. Any impact on leverage or share count will hinge on subsequent execution and disclosed amounts in future updates.

8-K Event Classification

3 items: 2.02, 8.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MPW announce in its latest 8-K?

MPW furnished Q3 2025 results and approved a stock repurchase program for up to $150 million of common stock.

How large is Medical Properties Trust’s new buyback?

The board authorized repurchases of up to $150 million of common stock.

What methods can MPW use to repurchase shares?

Open market purchases, Rule 10b5-1 trading plans, privately negotiated transactions, structured or derivative transactions, other equity contracts, and other lawful methods.

Is MPW required to repurchase shares under this program?

No. The company is under no obligation and may begin, suspend, or terminate repurchases at any time.

What financial materials did MPW provide with the announcement?

A press release with results for the three and nine months ended September 30, 2025, and a Q3 2025 supplemental information package.

What factors will influence MPW’s repurchase activity?

The company cited future liquidity, market conditions, regulatory considerations, and the marginal benefit of new investments and/or debt reduction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/30/2025 - 08:36 AM Learn about SEC filing dates

MEDICAL PROPERTIES TRUST INC false 0001287865 0001287865 2025-10-30 2025-10-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 30, 2025

MEDICAL PROPERTIES TRUST, INC.

(Exact Name of Registrant as Specified in Charter)

Commission File Number 001-32559

Maryland		20-0191742
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1000 Urban Center Drive, Suite 501 Birmingham, AL		35242
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code

(205) 969-3755

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.		MPW		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On October 30, 2025, Medical Properties Trust, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, this information shall not be deemed incorporated by reference in any filing of Medical Properties Trust, Inc. with the Securities and Exchange Commission, except as expressly set forth by specific reference in any such filing.

Item 8.01. Other Events.

On October 28, 2025, the board of directors of Medical Properties Trust, Inc. (the “Company”) approved a stock repurchase program (the “Stock Repurchase Program”) for up to $150 million of common stock, par value $0.001 per share, of the Company (the “Shares”). Repurchases may be effected from time to time through open market purchases (including trading plans that may be adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended), privately negotiated transactions, structured or derivative transactions, other equity contracts or other methods of acquiring shares.

The Company is under no obligation to repurchase any Shares and will evaluate any opportunities to do so in the context of the Company’s future liquidity profile, prevailing market conditions and regulatory considerations, as well as the potential marginal benefit of new investments and/or debt reduction. The Company may, in its discretion, begin, suspend or terminate repurchases at any time prior to the expiration of the Stock Repurchase Program, without any prior notice.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press release dated October 30, 2025 reporting financial results for the three and nine months ended September 30, 2025
99.2		Medical Properties Trust, Inc. 3rd Quarter 2025 Supplemental Information
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.

MEDICAL PROPERTIES TRUST, INC.
By:		/s/ R. Steven Hamner
Name:		R. Steven Hamner
Title:		Executive Vice President and Chief Financial Officer

Date: October 30, 2025

3